Global Medical Aesthetics Market

Global Medical Aesthetics Market Size, Share, Growth Analysis, By Product type(Cosmetic implants, facial aesthetic products. body contouring devices), By Application(Facial and body contouring, breast augmentation), By End-user(Hospitals, dermatology clinics), By Technology(Invasive, Non-Invasive), By Distribution Channel(Direct Tender and Retail) - Industry Forecast 2024-2031

Report ID: SQMIG35B2082 | Region: Global | Published Date: February, 2024
Pages: 263 | Tables: 146 | Figures: 78

To request a free sample copy of this report, please complete the form below.
What people say about us!

"We have purchased recently a report from SkyQuest Technology, and we are happy to inform you that this report was so useful and practical for our team. Skyquest Team was very active and our queries were followed up completely.It was amazing. "

- Mr. Ali Zali, Commercial Director, ICIIC Iran.

logos logos logos logos logos
Analyst Support
$5,300
BUY NOW
Want to customize this report?

Our industry expert will work with you to provide you with customized data in a short amount of time.

REQUEST FREE CUSTOMIZATION

FAQs

Medical Aesthetics Market size was valued at USD 13.1 billion in 2019 and is poised to grow from USD 14.4 billion in 2023 to USD 35.6 billion by 2031, growing at a CAGR of 10.1% in the forecast period (2024-2031).

Global medical aesthetics market is highly competitive and somewhat fragmented. To maintain a competitive edge, the major industry participants are continually implementing various growth strategies. Innovations, mergers, and acquisitions, collaborations and partnerships are adopted by these players to thrive in the competitive market. In order to provide industries with the most effective and economical solutions, the major market players are also continually concentrating on R&D. 'Cynosure', 'Cutera', ' Allergan plc   ', ' Alma Lasers Ltd.   ', ' Galderma S.A.   ', ' Johnson & Johnson Services, Inc.   ', ' Lumenis Ltd.   ', ' Merz Pharma GmbH & Co. KGaA   ', ' Nestlé Skin Health S.A.   ', ' Photomedex, Inc.   ', ' Sciton, Inc.   ', ' Sinclair Pharma plc   ', ' Syneron Medical Ltd.   ', ' Solta Medical, Inc.   ', ' Suneva Medical, Inc.   ', ' Valeant Pharmaceuticals International, Inc.   ', ' Venus Concept Canada Corp.   ', ' ZELTIQ Aesthetics, Inc.   ', ' Zimmer Biomet Holdings, Inc.   ', ' 3M Company '

The rising demand for aesthetic procedures that are less invasive such as dermal fillings and botulinum toxin A (BoNTA) is surging the growth of the medical aesthetics market during the forecast period. Nonsurgical facial rejuvenation using botulinum toxin and hyaluronic acid is highly adopted in Middle East and other regions. Moreover, facial rhythm correction and loss of volume are the result of aesthetic rejuvenation of the face; botulinum toxin injections are applied to correct dynamic rhytides, whereas dermal fillers help to increase the volume and improve static rhytides. The low cost and increasing aging population are driving the demand for dermal fillers.

Increasing popularity of the elective aesthetic procedures is currently a trend. Nonsurgical facial rejuvenation using botulinum toxin and hyaluronic acid is getting popular in different regions that are further supporting the market growth.

North America held the largest of the medical aesthetics market revenue share in 2021 and will likely retain the same during the aforementioned forecast period due to the improved healthcare infrastructure, usage of cosmetic procedures, increasing skin disorders, availability of advanced technologies, and the availability of board-certified and professional cosmetic surgeons in the region. The US is the largest contributor to the regional market.

Related Reports

Bifurcation Lesions Market
Buy Now GET FREE SAMPLE
Healthcare Wipes Market
Buy Now GET FREE SAMPLE
Mortuary Bags Market
Buy Now GET FREE SAMPLE
Nonwoven Surgical Drapes Market
Buy Now GET FREE SAMPLE

Feedback From Our Clients

Global Medical Aesthetics Market

Product ID: SQMIG35B2082

$5,300
BUY NOW